What’s new in HRR testing?
Episode 2. As HRR testing becomes more embedded in mPC care, how do we balance scientific progress with real-world implementation across diverse clinical settings? Alicia Morgans and Joaquin Mateo break down the latest congress insights, impactful trials, and evolving guidelines shaping HRR testing. Mateo shares practical insights on making genomic test results meaningful in multidisciplinary teams, discusses the realities of HRR testing panel selection and access, and explores how liquid biopsy and workflow innovations are changing general approaches to HRR testing. View transcript.
Chapters
00:00 Welcome and introductions
00:39 Congress insights on HRR in mCRPC
01:53 Impactful HRR trials in mCRPC
03:16 Guideline changes in HRR testing
04:38 Local considerations in HRR testing
07:21 Guidance shaping HRR testing today
09:05 HRR panels in current practice
12:06 Promising advances in HRR testing
15:05 Multidisciplinary HRR adaptations
18:29 Future directions in HRR testing
Meet the guest speaker
Joaquin Mateo, MD, PhD
Joaquin Mateo is Group Leader of the Prostate Cancer Research Group at Vall d’Hebron Institute of Oncology (VHIO) and a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain. His research focuses on prostate cancer genomics and precision oncology, with key contributions to PARP inhibitor development and biomarker discovery.
Disclosures: Advisor for AstraZeneca, Amunix/Sanofi, Daiichi-Sankyo, Janssen, MSD, Pfizer, and Roche. Scientific board member for Nuage Therapeutics. Investigator in several pharma-sponsored clinical trials. Principal investigator of grants funded by Amgen, AstraZeneca, and Pfizer to VHIO.
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.